Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B20c647dbc8ec6bee9e80f01e8c962839> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B20c647dbc8ec6bee9e80f01e8c962839 NCIT_P378 "CDISC-GLOSS" @default.
- B20c647dbc8ec6bee9e80f01e8c962839 type Axiom @default.
- B20c647dbc8ec6bee9e80f01e8c962839 annotatedProperty NCIT_P325 @default.
- B20c647dbc8ec6bee9e80f01e8c962839 annotatedSource NCIT_C156635 @default.
- B20c647dbc8ec6bee9e80f01e8c962839 annotatedTarget "The EU procedure to be used when a product is already authorized in at least one Member State and the Marketing Authorization Holder wishes to obtain a Marketing Authorization (MA) for the same product in at least one other Member State. The Member State that has already authorized the product is known as the Reference Member State (RMS). The RMS submits their evaluation of the product to other Member State/s, these are known as Concerned Member State/s (CMS). If the applicant is successful, the CMS will then issue a MA for that product permitting the marketing of that product in their country. [After Heads of Medicines Agencies (HMA) website http://www.hma.eu/medicinesapprovalsystem.html] See also Reference Member State (RMS) and Concerned Member State (CMS)." @default.